The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 13, 2023

Filed:

Apr. 06, 2018
Applicant:

Altergon SA, Lugano, CH;

Inventors:

Luca De Stefano, Naples, IT;

Ilaria Rea, Caivano, IT;

Principia Dardano, Ercolano, IT;

Luigi Nicolais, Ercolano, IT;

Assignee:

Altergon SA, Lugano, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 37/00 (2006.01); A61K 9/00 (2006.01); A61N 5/06 (2006.01);
U.S. Cl.
CPC ...
A61M 37/0015 (2013.01); A61K 9/0021 (2013.01); A61N 5/062 (2013.01); A61M 2037/0007 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0061 (2013.01); A61N 2005/063 (2013.01); A61N 2005/0659 (2013.01); A61N 2005/0662 (2013.01);
Abstract

The object of the present invention is a device () for the transdermal delivery of active molecules. The device () comprises a support element () and a plurality of micro-needles () that protrude from a first surface of the support element (), the support element () and the micro-needles () being both permeable to the active molecules. The device () further comprises a porous membrane () configured to be loaded with said active molecules, which lies on a second surface of the support element (). Characteristically, the porous membrane () is configured to behave, from an optical viewpoint, as a Bragg mirror. Further objects of the present invention are the following uses of the device (): for monitoring the release and/or the decay of the active molecules, for the optical control of the release of the active molecules and for the thermal control of the release of the active molecules. Lastly, an object of the present invention is the method for producing the device () for transdermal delivery of active molecules.


Find Patent Forward Citations

Loading…